Kamil Ali-Jackson | Co-Founder and Chief Legal Officer |
Neal Walker | Co-Founder Chief Executive Officer, President and Director |
Stuart Shanler | Co-Founder and Chief Scientific Officer |
Jeff Wayne | Interim Chief Commercial Officer |
Frank Ruffo | Co-Founder and Chief Financial Officer |
David Gordon | Chief Medical Officer |
Blair Cohen | Guggenheim Securities |
Timothy Lugo | William Blair |
Good day, ladies and gentlemen, and welcome to the Aclaris Therapeutics Fourth Quarter 2018 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to Kamil Ali-Jackson, Chief Legal Officer. Ma'am, you may begin.
Thank you.